🚀 VC round data is live in beta, check it out!

ASP Isotopes Valuation Multiples

Discover revenue and EBITDA valuation multiples for ASP Isotopes and similar public comparables like Explosifs et Produits Chimiques, AdvanSix, SP Group, AECI and more.

ASP Isotopes Overview

About ASP Isotopes

ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.


Founded

2001

HQ

United States

Employees

136

Sectors

Financials (LTM)

Revenue: $26M
EBITDA: ($44M)

EV

$545M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

ASP Isotopes Financials

ASP Isotopes reported last 12-month revenue of $26M and negative EBITDA of ($44M).

In the same LTM period, ASP Isotopes generated $7M in gross profit, ($44M) in EBITDA losses, and had net loss of ($152M).

Revenue (LTM)


ASP Isotopes P&L

In the most recent fiscal year, ASP Isotopes reported revenue of $24M and EBITDA of ($50M).

ASP Isotopes is unprofitable as of last fiscal year, with gross margin of 14%, EBITDA margin of (208%), and net margin of (734%).

See analyst estimates for ASP Isotopes
LTMLast FY202320242025202620272028
Revenue$26M$24M$433K$4M$24M
Gross Profit$7M$3M$139K$2M$3M
Gross Margin25%14%32%39%14%
EBITDA($44M)($50M)($16M)($32M)($157M)
EBITDA Margin(168%)(208%)(3728%)(762%)(659%)
EBIT Margin(216%)(240%)(3705%)(636%)(240%)
Net Profit($152M)($175M)($16M)($32M)($175M)
Net Margin(583%)(734%)(3761%)(780%)(734%)

Financial data powered by Morningstar, Inc.

ASP Isotopes Stock Performance

ASP Isotopes has current market cap of $662M, and enterprise value of $545M.

Market Cap Evolution


ASP Isotopes' stock price is $5.26.

ASP Isotopes share price decreased by 30.4% in the last year.

ASP Isotopes has an EPS (earnings per share) of $-1.39.

See more trading valuation data for ASP Isotopes
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$545M$662M6.5%—-1.5%-30.4%$-1.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

ASP Isotopes Valuation Multiples

ASP Isotopes trades at 20.9x EV/Revenue multiple, and (12.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for ASP Isotopes

EV / Revenue (LTM)


ASP Isotopes Financial Valuation Multiples

As of May 1, 2026, ASP Isotopes has market cap of $662M and EV of $545M.

ASP Isotopes has a P/E ratio of (4.3x).

LTMLast FY202320242025202620272028
EV/Revenue20.9x22.8xn/m131.5x22.8x
EV/EBITDA(12.4x)(11.0x)(33.8x)(17.3x)(3.5x)
EV/EBIT(9.7x)(9.5x)(34.0x)(20.7x)(9.5x)
EV/Gross Profit83.1x160.0xn/mn/m160.0x
P/E(4.3x)(3.8x)(40.7x)(20.5x)(3.8x)
EV/FCF(15.1x)(11.5x)(70.4x)(19.4x)(11.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified ASP Isotopes Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

ASP Isotopes Margins & Growth Rates

ASP Isotopes grew revenue by 29% but EBITDA decreased by 35% in the last fiscal year.

In the most recent fiscal year, ASP Isotopes reported gross margin of 14%, EBITDA margin of (208%), and net margin of (734%).

See estimated margins and future growth rates for ASP Isotopes

ASP Isotopes Margins

Last FY202420252026202720282029
Gross Margin14%39%14%45%
EBITDA Margin(208%)(762%)(659%)(105%)
EBIT Margin(240%)(636%)(240%)(167%)
Net Margin(734%)(780%)(734%)(347%)
FCF Margin(199%)(677%)(199%)(43%)

ASP Isotopes Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth29%857%475%29%
Gross Profit Growth310%1051%113%310%
EBITDA Growth(35%)96%397%(79%)
EBIT Growth(10%)64%117%(10%)
Net Profit Growth(39%)99%442%(39%)
FCF Growth(72%)262%69%(72%)

Data powered by FactSet, Inc. and Morningstar, Inc.

ASP Isotopes Operational KPIs

ASP Isotopes' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.

ASP Isotopes' Rule of 40 is (77%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

ASP Isotopes' Rule of X is (34%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for ASP Isotopes
LTMLast FY202320242025202620272028
Rule of 40(84%)(77%)———
Bessemer Rule of X41%(34%)———
Revenue per Employee—$0.2M———
Opex per Employee—$0.4M———
G&A Expenses to Revenue—202%3560%599%202%
R&D Expenses to Revenue52%56%177%76%52%
Opex to Revenue—254%3737%675%254%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

ASP Isotopes Competitors

ASP Isotopes competitors include Explosifs et Produits Chimiques, AdvanSix, SP Group, AECI, SGL Carbon, Flotek Industries, Gujarat State Fertilizers, Alok Indus, Sheela Foam and Alujain.

Most ASP Isotopes public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Explosifs et Produits Chimiques1.4x1.2x10.0x8.6x
AdvanSix0.7x0.7x7.2x6.9x
SP Group1.6x1.5x7.7x7.2x
AECI0.3x0.3x3.1x3.1x
SGL Carbon0.8x0.8x7.4x6.6x
Flotek Industries2.8x2.6x25.8x18.2x
Gujarat State Fertilizers0.5x0.5x5.5x6.6x
Alok Indus8.8x—247.2x—

This data is available for Pro users. Sign up to see all ASP Isotopes competitors and their valuation data.

Start Free Trial

ASP Isotopes M&A Activity

ASP Isotopes has acquired 2 companies to date.

Last acquisition by ASP Isotopes was on May 20th 2025. ASP Isotopes acquired Renergen for $107M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by ASP Isotopes

Renergen
PET Labs Pharmaceuticals
Description
Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.
PET Labs Pharmaceuticals is a Cape Town-headquartered radiopharmaceutical firm focused on nuclear medicine. The company develops and supplies positron emission tomography tracers for oncology, cardiology, and neurology diagnostics in South Africa. Equipped with cyclotrons and production facilities compliant with international standards, PET Labs serves public and private hospitals, enabling early cancer detection through tailored isotope solutions. Established in 2015, it supports over 20 PET scanners nationwide and collaborates with the South African Nuclear Energy Corporation for isotope supply.
HQ CountrySouth AfricaSouth Africa
HQ City
Johannesburg
Johannesburg
Deal Date20 May 202529 Oct 2023
Valuation$107M$4M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ASP Isotopes acquisitions and their M&A valuation multiples.

Start Free Trial

ASP Isotopes Investment Activity

ASP Isotopes has invested in 2 companies to date.

Latest investment by ASP Isotopes was on November 7th 2025. ASP Isotopes invested in Quantum Leap Energy in their $64M Undisclosed stage round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by ASP Isotopes

Quantum Leap Energy
Isobio
Description
Quantum Leap Energy is a Pretoria, South Africa-based subsidiary of ASP Isotopes Inc. The company develops isotope enrichment technologies for medical imaging, semiconductor fabrication, and green energy applications. It operates laser-based facilities producing stable isotopes like Molybdenum-100 and Silicon-28 for global supply chains.
—
HQ CountryUnited StatesUnited States
HQ City
Washington, DC
—
Deal Date7 Nov 202528 Jul 2025
RoundUndisclosed stageSeed
Raised$64M$5M
InvestorsAmerican Ventures; ASP Isotopes; Donald Trump Jr.; Eric TrumpASP Isotopes
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ASP Isotopes investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About ASP Isotopes

When was ASP Isotopes founded?ASP Isotopes was founded in 2001.
Where is ASP Isotopes headquartered?ASP Isotopes is headquartered in United States.
How many employees does ASP Isotopes have?As of today, ASP Isotopes has over 136 employees.
Who is the CEO of ASP Isotopes?ASP Isotopes' CEO is Robert Ainscow.
Is ASP Isotopes publicly listed?Yes, ASP Isotopes is a public company listed on Nasdaq.
What is the stock symbol of ASP Isotopes?ASP Isotopes trades under ASPI ticker.
When did ASP Isotopes go public?ASP Isotopes went public in 2022.
Who are competitors of ASP Isotopes?ASP Isotopes main competitors include Explosifs et Produits Chimiques, AdvanSix, SP Group, AECI, SGL Carbon, Flotek Industries, Gujarat State Fertilizers, Alok Indus, Sheela Foam, Alujain.
What is the current market cap of ASP Isotopes?ASP Isotopes' current market cap is $662M.
What is the current revenue of ASP Isotopes?ASP Isotopes' last 12 months revenue is $26M.
What is the current revenue growth of ASP Isotopes?ASP Isotopes revenue growth (NTM/LTM) is 84%.
What is the current EV/Revenue multiple of ASP Isotopes?Current revenue multiple of ASP Isotopes is 20.9x.
Is ASP Isotopes profitable?No, ASP Isotopes is not profitable.
What is the current EBITDA of ASP Isotopes?ASP Isotopes has negative EBITDA and is not profitable.
What is ASP Isotopes' EBITDA margin?ASP Isotopes' last 12 months EBITDA margin is (168%).
What is the current EV/EBITDA multiple of ASP Isotopes?Current EBITDA multiple of ASP Isotopes is (12.4x).
What is the current FCF of ASP Isotopes?ASP Isotopes' last 12 months FCF is ($36M).
What is ASP Isotopes' FCF margin?ASP Isotopes' last 12 months FCF margin is (138%).
What is the current EV/FCF multiple of ASP Isotopes?Current FCF multiple of ASP Isotopes is (15.1x).
How many companies ASP Isotopes has acquired to date?As of May 2026, ASP Isotopes has acquired 2 companies.
What was the largest acquisition by ASP Isotopes?$107M acquisition of Renergen on 20th May 2025 was the largest M&A ASP Isotopes has done to date.
What companies ASP Isotopes acquired?ASP Isotopes acquired Renergen and PET Labs Pharmaceuticals.
In how many companies ASP Isotopes has invested to date?As of May 2026, ASP Isotopes has invested in 2 companies.
What was the last ASP Isotopes investment?On 7th November 2025 ASP Isotopes invested in Quantum Leap Energy, participating in a $64M Undisclosed stage round, alongside American Ventures, Donald Trump Jr., and Eric Trump.
In what companies ASP Isotopes invested in?ASP Isotopes invested in Quantum Leap Energy and Isobio.

See public comps similar to ASP Isotopes

Lists including ASP Isotopes

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial